GGTLC1 and neoplasm: Additionally, circulating tumor cells (CTCs) and the alkaline phosphatase plus gamma-glutamyl transpeptidase to lymphocyte ratio (AGLR) have demonstrated prognostic value, particularly in assessing disease progression and vascular invasion [7].